Paget's disease of bone is a long-term condition that changes how bone breaks down and rebuilds. It can cause bone pain, enlarged or misshapen bones, joint stiffness, and sometimes hearing changes if the skull is involved. Many people with Paget's disease of bone have no symptoms and learn about it on an X-ray or blood test, but others notice gradual pain or trouble with walking. It mainly affects adults over 50, and the outlook varies, but many people live long and full lives with care. Treatment often includes pain relief, bone-strengthening medicines like bisphosphonates, and sometimes surgery for complications.
Overview
Paget's disease of boneSymptoms
Paget's disease of bone often causes no symptoms. Early symptoms of Paget's disease of bone can include bone pain, warmth over a bone, and stiff joints. Others notice bowed legs, enlarged skull with headaches or hearing loss, or fractures.
Outlook and prognosis
Most people with Paget’s disease of bone live many years with good function when it’s found early and managed. Treatment can ease pain, slow overactive bone changes, and reduce fracture risk. Regular check-ins help prevent joint strain, nerve pressure, and hearing loss.
Causes and risk factors
Paget's disease of bone likely stems from genetic susceptibility plus environmental influences. Key risk factors for Paget's disease of bone include older age, male sex, European ancestry, and family history (inherited variants); geographic clustering hints at additional, still-uncertain environmental triggers.
Genetic influences
Genetics plays a meaningful role in Paget’s disease of bone, especially with family history. Variants in genes such as SQSTM1 and others can raise risk and influence severity. Still, many people with Paget’s disease have no known genetic change.
Diagnosis
Doctors diagnose Paget's disease of bone using your history and exam, X-rays or bone scan, and blood tests—especially raised alkaline phosphatase. Imaging shows characteristic changes. Additional tests help rule out other causes; biopsy is rarely needed.
Treatment and drugs
Treatment for Paget’s disease of bone focuses on easing pain, slowing overactive bone turnover, and protecting joints. Many benefit from bisphosphonates or calcitonin, plus vitamin D and calcium as advised. Targeted pain relief, physical therapy, and surgery for fractures or arthritis are sometimes used.
Symptoms
Paget's disease of bone can be quiet for years, and many people have no symptoms. You might notice small changes at first—an aching hip after a short walk, a hat that feels tight, or new ringing in an ear—depending on which bones are involved. Symptoms vary from person to person and can change over time. Early symptoms of Paget's disease of bone often include dull, constant bone pain or joint stiffness.
Dull, aching pain in one or more bones is the most common symptom. It can be constant and worse at night or after activity. In Paget's disease of bone, pain often centers in the hip, pelvis, spine, or skull.
Nearby joints can become sore and stiff as the reshaped bone changes how they move. This can feel like osteoarthritis around the hip, knee, or shoulder. Daily tasks like climbing stairs may feel harder.
Affected bones can grow larger or change shape over time. Rings, shoes, or a hat may stop fitting the way they used to. In Paget's disease of bone, the shin, thigh bone, pelvis, or skull are common sites.
When the leg bones curve, walking can feel unsteady or tiring. Knees and hips may ache from the extra strain.
How people usually first notice Paget's disease of bone?
People often first notice Paget’s disease of bone when a bone starts aching for months, an area becomes warm or enlarged, or a hat or ring size quietly creeps up without weight gain. Others discover it after a low-energy fracture, new bowing of a leg, gradual hearing loss from skull involvement, or an elevated alkaline phosphatase level on a routine blood test that prompts an X-ray or bone scan. For many, these early changes are subtle and painless, so the “first signs of Paget’s disease of bone” are often picked up during evaluation for persistent bone pain, a deformity, or an unexpected lab finding.
Types of Paget's disease of bone
Paget’s disease of bone has a few well-described patterns that help explain why symptoms vary so much from person to person. Some people have just one bone involved, while others have several, and certain bones tend to cause more day-to-day problems than others. Symptoms don’t always look the same for everyone. When people look up types of Paget’s disease of bone, they’re usually asking how the number and location of affected bones change the picture.
Monostotic type
Only one bone is involved, often the pelvis, skull, femur, or spine. Pain may be localized and found during an X-ray for another reason. Function often stays near normal unless the affected bone bears heavy load.
Polyostotic type
Two or more bones are affected, sometimes on both sides of the body. People may notice more widespread pain, limb bowing, or stiffness. There’s a higher chance of joint strain and secondary arthritis.
Skull involvement
The skull is the main site, with headaches, scalp tenderness, or changes in hat size. Some may notice hearing changes if the bone near the ear is affected. Vision changes are less common but can occur if eye sockets are involved.
Spine involvement
The spine is affected, which can cause back pain and nerve-related symptoms like tingling or weakness if nerves are compressed. Posture changes may develop over time. Walking tolerance can drop on busier days.
Pelvis involvement
The pelvis bears much of the body’s weight, so pain often shows with standing or walking. Hip stiffness and limping can develop if nearby joints are stressed. Night pain can flare after active days.
Long bone involvement
Thigh or shin bones can thicken and bow, leading to aching with activity. People may notice one leg feels heavier or alignment looks off. Stress fractures can occur with repetitive load.
What genetics can tell you about symptoms
Some people with Paget’s disease of bone inherit changes in the SQSTM1 gene, which can lead to bone pain, enlarged or misshapen bones, and fractures. These variants make bone cells remodel too quickly and unevenly, causing joint problems, nerve compression, and hearing loss.
Causes and risk factors
The cause of Paget's disease of bone is unclear, and both inherited traits and environment likely play roles. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Risk factors for Paget's disease of bone include older age, being male, and having a close relative with the condition. Risk is also higher in people of European ancestry and in regions such as the UK, Western Europe, and North America. Lifestyle factors have not been proven to cause it, and possible links with past viral infections remain unconfirmed.
Environmental and biological risk factors
Paget's disease of bone becomes more likely under certain body-based and environmental conditions. Doctors often group risks into internal (biological) and external (environmental). Knowing your background and surroundings can help you and your clinician decide when to watch more closely; if you’re concerned, bring up any early symptoms of Paget's disease of bone during a visit. Below are the factors that are well supported by research.
Risk rises steadily after midlife and is highest after about age 50. Age-related shifts in bone cell activity make Paget's disease of bone more likely. It is uncommon before age 40.
Men develop the condition more often than women. The reason is not fully understood, but sex-related biological differences in bone turnover likely play a role.
Rates are higher in people of European descent and lower in many Asian and African populations. This pattern suggests underlying biological susceptibility tied to population background.
Living in the UK, parts of Western Europe, North America, Australia, or New Zealand has been linked with higher rates of Paget's disease of bone. This likely reflects who lives there and long-standing local influences in those regions.
Genetic risk factors
Genetics play a meaningful role in who develops Paget's disease of bone. Some risk factors are inherited through our genes. A few rare gene changes carry a high chance within a family, while several common gene variants each add a small amount of risk. In families with multiple affected relatives, genetic testing may be considered, sometimes even before any early symptoms of Paget's disease of bone appear.
Family history: Having a parent or sibling with Paget's disease of bone raises your chance several-fold. Clusters across generations suggest shared genetic changes. Families with multiple relatives affected often see earlier recognition.
SQSTM1 variants: Changes in the SQSTM1 gene (sometimes called p62) are the most common known cause in affected families with Paget's disease of bone. These variants can greatly increase risk but do not guarantee disease. Effects tend to appear in later adulthood.
RANK genes: Rare activating changes in TNFRSF11A (a RANK gene) can cause early-onset bone overgrowth that resembles classic disease. These changes often run strongly in families. They may lead to faster bone turnover at younger ages.
Cell cleanup genes: Variants in OPTN and VCP, which help cells clear waste and balance signals, have been linked to disease risk. Their impact is usually moderate and varies between families. Some relatives may carry a variant yet never show bone changes on scans.
Common risk variants: Several widespread gene markers, including regions near CSF1, RIN3, and OPTN, each add a small amount of risk for Paget's disease of bone. The effects are additive rather than all-or-nothing. No single marker is enough on its own.
European ancestry: The condition is more frequent in people with British, Irish, Spanish, or Western European roots, reflecting shared inherited background. Certain families show founder effects, where the same variant was passed down from distant ancestors. People from other ancestries can still be affected.
Age-linked effects: Even with a risk variant, Paget's disease of bone often does not appear until mid-to-late adulthood. Risk is not destiny—it varies widely between individuals. This age pattern can make screening in high-risk families more focused later in life.
Dominant inheritance: When the disease runs in a family, one altered copy of a risk gene can be enough for susceptibility. Not everyone who inherits it will develop features, and severity can differ widely. This pattern explains why multiple generations may be affected.
Lifestyle risk factors
Several lifestyle habits can influence symptoms, complications, and day-to-day function in Paget's disease of bone. While they do not cause the condition, they can affect pain, fracture risk, and joint strain. Understanding the lifestyle risk factors for Paget's disease of bone can help prioritize safer choices.
Inadequate intake can worsen bone pain and raise fracture risk in already fragile pagetic bone. Ensuring sufficient vitamin D and calcium supports healthier remodeling during treatment.
Sedentary habits weaken muscles that stabilize affected bones and nearby joints, worsening pain and mobility. Regular low-impact, weight-bearing activity can improve strength and function.
Running, jumping, or heavy lifting increase microtrauma and fracture risk in pagetic bone. Choosing low-impact activities reduces stress on weakened areas.
Tobacco impairs bone blood flow and healing, increasing risk of delayed recovery after fractures or surgery in Paget’s disease. Quitting supports better bone remodeling and surgical outcomes.
Risk prevention
Paget's disease of bone can’t be fully prevented because age and inherited factors play a big role. Prevention is about lowering risk, not eliminating it completely. For many, the focus is catching changes early and protecting bone strength to avoid fractures and joint problems. If you have a family history or unexplained bone pain, targeted checks can make a difference.
If a parent or sibling has Paget’s disease of bone, ask about periodic blood tests for bone turnover (alkaline phosphatase) after about age 40. Catching changes early can allow treatment before bone deformity or arthritis develops. Knowing early symptoms of Paget's disease of bone—persistent bone pain or warmth over a bone—can also prompt timely checks.
Aim for enough calcium in food and keep vitamin D at a healthy level to support strong bones. This can lower fracture risk if Paget’s weakens part of a bone. Ask your clinician about safe supplement doses if your diet is low.
Choose low-impact activity plus strength and balance exercises to protect muscles and bones. Avoid high-impact or twisting moves if a painful area could be affected. A physical therapist can tailor a plan if Paget’s is suspected or diagnosed.
Improve lighting, clear clutter, and install handrails to reduce falls. Well-fitting shoes and balance training further protect bones that could be fragile with Paget’s.
Transmission
Paget's disease of bone is not contagious; you cannot catch it or pass it on through everyday contact, sex, blood, pregnancy, or breastfeeding. It can run in families due to changes in genes that guide bone renewal, a pattern often described as autosomal dominant, meaning a single altered copy can raise risk.
If a parent carries a known gene change linked to Paget's disease of bone, each child has about a 50% chance of inheriting that change, but not everyone who inherits it will develop the condition. Many people with Paget's disease of bone have no family history because the change can arise for the first time in them. If you're concerned about the genetic transmission of Paget's disease of bone or how Paget's disease of bone is inherited, a genetics professional can explain your family’s specific risk.
When to test your genes
Consider genetic testing if Paget’s disease of bone runs in your family, especially with an affected first‑degree relative, early onset, or multiple bones involved. Testing may help with earlier screening and tailored care, particularly when symptoms are unclear. Ask your clinician or a genetic counselor about timing, benefits, and limits.
Diagnosis
For many, the first step comes when everyday activities start feeling harder, like new bone pain, a larger hat size, or hearing changes that don’t add up. The diagnosis of Paget’s disease of bone often starts with these clues and moves toward targeted tests to confirm the cause and check how many bones are involved. Doctors usually begin with a careful history, physical exam, and simple blood work before ordering imaging. Some diagnoses are clear after a single visit, while others take more time.
Your provider asks about bone pain, changes in head size or limb shape, and family history. They examine tender or enlarged bones and joint movement to spot patterns that suggest Paget’s disease of bone. These findings guide which tests come next.
A standard panel often includes alkaline phosphatase, which is commonly higher when bone turnover is active. Other labs help rule out liver causes and check calcium and vitamin D. Results help estimate activity but don’t show which bones are involved.
Targeted X-rays look for typical changes in affected bones, such as areas that look both thickened and fragile. These imaging findings support the clinical picture. They also help distinguish Paget’s disease of bone from fractures or old injuries.
A nuclear medicine bone scan maps active bone changes throughout the body. It’s useful to see how many bones are involved, even if they don’t hurt yet. This helps with treatment planning and follow-up.
Stages of Paget's disease of bone
Paget's disease of bone is often described in phases that reflect how the bone changes over time. Different bones in the same person can be in different phases at once, and early symptoms of Paget's disease of bone may be mild or absent. Many people feel reassured knowing what their tests can—and can’t—show. Doctors usually use a mix of X‑rays, bone scans, and blood tests to see which phase a bone is in and how active the disease is.
Lytic phase
Bone is broken down faster than usual, so X‑rays may show areas that look “eaten away.” Pain or warmth over the area can occur, though some have no symptoms.
Mixed phase
Bone breakdown and overgrowth happen together, leading to enlarged, misshapen bone on imaging. This phase can bring aching, bowing of long bones, or higher fracture risk.
Sclerotic phase
Bone building dominates, creating very dense but mechanically brittle bone. Pain may come from nearby joints or pinched nerves rather than from active bone change itself.
Burnt-out phase
Disease activity quiets and blood markers may return toward normal. Symptoms can persist due to permanent bone shape changes, so periodic monitoring still matters.
Outlook and prognosis
Many people ask, “What does this mean for my future?”, and the short answer is that most people with Paget’s disease of bone live a normal lifespan. The condition tends to progress slowly, often staying limited to a few bones like the pelvis, spine, skull, or leg. When symptoms show up, they’re usually bone pain, warmth over an affected area, changes in head size, or joint trouble near the involved bone. Early symptoms of Paget’s disease of bone can be subtle, so regular check-ins and blood tests for alkaline phosphatase help track activity and guide treatment.
Prognosis refers to how a condition tends to change or stabilize over time. With modern care—pain control, physical therapy, and medicines that calm overactive bone cells—many people maintain good function and avoid major complications. The biggest long-term risks are fractures in weakened bone, arthritis in nearby joints, nerve compression from enlarged bone, and rare hearing loss when the skull is involved. Life-threatening complications are uncommon; transformation to bone cancer (osteosarcoma) is very rare, reported in far fewer than 1% of people with Paget’s disease of bone, but it calls for urgent evaluation if sudden severe pain, swelling, or new lumps appear.
Looking at the long-term picture can be helpful. Treated disease often stabilizes for years, and pain usually improves, though some people need repeat courses of therapy over time. If the hip, knee, or spine is involved, mobility and balance can change; planning for home safety, joint-friendly exercise, and fall prevention keeps you active and independent. Talk with your doctor about what your personal outlook might look like, including how often to monitor labs and imaging, when to treat, and what warning signs should prompt a call.
Long-term effects
Paget's disease of bone can change how certain bones grow and repair, leading to problems that build over years. Long-term effects vary widely, and not everyone has the same pattern or pace of change. When the disease stays active, bones can become painful, misshapen, and more fragile, which can limit daily activities. Because early symptoms of Paget's disease of bone are often subtle, some long-term issues may only surface after imaging or a fracture.
Ongoing aching or deep soreness can develop in affected bones. Pain may worsen with activity or at night. It often reflects active bone remodeling.
Bones can enlarge or bend over time, such as a bowed leg or a larger skull. These changes may shift body mechanics and posture. Visible changes can progress slowly.
Weakened bone structure raises the risk of breaks with minor falls. Fractures may occur in long bones, pelvis, spine, or skull. Healing can be slower or more complex.
Nearby joints can wear down due to altered bone shape and alignment. This can cause stiffness, swelling, and pain around hips, knees, or spine. Over time, movement may feel limited.
How is it to live with Paget's disease of bone?
Living with Paget’s disease of bone often means adapting to cycles of aching, stiffness, and fatigue that can flare after activity and ease with rest, while staying alert to joints that feel uneven or a limb that seems subtly bowed. Daily life may involve pacing tasks, using assistive devices during bad days, and keeping regular appointments to track bone changes and hearing, especially if the skull is affected. Many find that clear communication helps loved ones understand why plans shift, why lifting or long walks are limited, and how small support—rides to appointments, help with chores, shared exercise routines—can make a big difference. With treatment, smart activity choices, and support at home and work, most people maintain independence and protect function over time.
Treatment and drugs
Treatment for Paget’s disease of bone focuses on easing pain, slowing the overactive bone changes, and preventing complications like fractures or joint trouble. Doctors often use medicines that calm down bone turnover; these are called bisphosphonates, and they may be given as pills or an infusion depending on your needs. Pain relievers, gentle physical therapy, and supportive devices like shoe inserts or a cane can help with day-to-day comfort and mobility, while vitamin D and calcium are usually checked and supplemented if low. If a bone is badly misshapen, pressing on nerves, or at high risk of breaking, an orthopedic surgeon may recommend a procedure to realign or stabilize it. Not every treatment works the same way for every person, so your doctor may monitor blood tests (like alkaline phosphatase), symptoms, and imaging and then adjust the plan over time.
Non-drug treatment
Alongside medicines, non-drug therapies can steady pain, protect joints, and help you stay active with Paget's disease of bone. Early symptoms of Paget's disease of bone can be subtle, so care often starts with simple steps that support balance, strength, and daily function. These approaches aim to lower stress on affected bones, reduce fall risk, and ease strain on nearby joints. Your plan is tailored to which bones are involved and how your symptoms change over time.
Targeted stretches and strengthening routines can steady joints and reduce strain on affected bones. A therapist can tailor exercises to your pain level and mobility.
Low-impact activities like walking, cycling, or water exercise help maintain strength without pounding your bones. A gradual plan prevents flare-ups and protects balance.
A cane, walker, or trekking pole can offload a painful hip, knee, or spine and reduce fall risk. Shoe lifts may help if leg lengths differ due to bone changes.
A knee brace, spinal support, or custom insoles can stabilize joints and improve alignment. This can ease pain during standing, stairs, or longer walks.
Your genes may have an impact on how drugs work for you
Two people with Paget’s disease of bone can respond very differently to bisphosphonates because genetic differences affect drug targets, transport, and metabolism. Variants in genes involved in bone remodeling or liver and kidney processing can change effectiveness, side effects, or dosing needs.
Pharmacological treatments
Medicines can slow overactive bone turnover and ease pain so daily movement is easier. In Paget's disease of bone, bisphosphonates are the mainstay because they quiet the cells that break down bone and can lead to long remissions. First-line medications are those doctors usually try first, based on how well they work and safety, and here that’s usually zoledronic acid given by vein or oral options like risedronate. Many people have few early symptoms of Paget's disease of bone, so treatment may begin after blood tests or scans show active disease or when pain develops.
A single 5 mg intravenous infusion often puts Paget's disease of bone into remission for years. Flu-like symptoms can occur for a day or two; ensuring good vitamin D and calcium levels lowers the risk of low blood calcium.
Risedronate or alendronate help calm overactive bone and reduce pain. They are taken with a full glass of water on an empty stomach, and staying upright for 30–60 minutes helps prevent stomach irritation.
This intravenous bisphosphonate is an option if oral medicines aren’t tolerated or if zoledronic acid isn’t suitable. It’s given over a few hours and can be repeated; kidney function and calcium levels are checked.
Used when bisphosphonates can’t be taken, it may lessen bone pain and biochemical activity in Paget's disease of bone. It is generally less effective and can cause nausea or flushing with ongoing use.
Genetic influences
In some families, Paget's disease of bone appears more often than expected, pointing to an inherited component. Family history is one of the strongest clues to a genetic influence. Research has identified changes in genes that help control how old bone is broken down and rebuilt in a portion of people with Paget’s, but environment and aging also play a part. A gene change can raise your chances, yet it isn’t destiny, and even within one family the pattern of bones affected and the severity can differ. If a parent or sibling has Paget's, your clinician may suggest periodic check-ins or, in some cases, a visit with a genetics team to discuss the pros and cons of testing. Genes can shape risk, but they can’t forecast early symptoms of Paget's disease of bone, so ongoing monitoring and imaging remain important.
Is Paget's disease of bone genetic?
Genetics plays a meaningful role in Paget’s disease of bone, especially with family history. Variants in genes such as SQSTM1 and others can raise risk and influence severity. Still, many people with Paget’s disease have no known genetic change.
Pharmacogenetics—how genetics influence drug effects
Most people with Paget’s disease of bone are treated with medicines that slow down overactive bone cells, such as bisphosphonates given by infusion or as tablets. Not every difference in response is genetic, but small differences in your genes can influence how strongly a medicine works, how long it stays in your body, or whether side effects show up; this field is called pharmacogenetics. Right now, there isn’t a standard pharmacogenetic test used to choose or dose bisphosphonates for Paget’s disease of bone, so doctors base decisions on how active the disease is, kidney function, vitamin D and calcium levels, and your past reactions. Inherited changes that raise the chance of developing Paget’s disease can be linked with more widespread or active disease, which may lead your care team to treat earlier or use a longer-acting drug, but these gene findings do not dictate a specific prescription. Research is exploring whether certain gene patterns relate to rare problems like jaw bone damage with bisphosphonates, yet these links aren’t strong enough to guide everyday care. If side effects or a lack of relief have been an issue, talk with your clinician about options such as switching to a different bisphosphonate, using calcitonin when appropriate, adjusting timing or route, and whether pharmacogenetic testing for Paget’s disease of bone could be helpful in your situation.
Interactions with other conditions
For many, joint problems like osteoarthritis tend to flare where Paget's disease of bone has changed the shape or alignment of nearby bones, making everyday movements stiffer and more painful. Doctors call it a “comorbidity” when two conditions occur together, and osteoarthritis, osteoporosis, and long‑standing back problems often overlap with Paget’s. If the skull is involved, hearing loss may worsen when an ear disorder is already present, and spine involvement can add pressure on nerves in someone who already has sciatica or spinal stenosis. When Paget’s affects large areas of bone, the extra blood flow through bone can strain the heart, so preexisting heart disease or anemia may lead to shortness of breath or swelling more quickly than expected.
Low vitamin D, parathyroid problems, or long periods of bed rest can raise blood calcium in people with Paget’s, which may turn early symptoms of Paget’s disease of bone—such as dull bone pain—into sudden thirst, confusion, or constipation that needs urgent care. Osteoporosis can be present at the same time, and while the two conditions are different, together they raise the chance of fractures and may require tailored treatment plans. Some medications used for Paget’s need dose changes in chronic kidney disease or may interact with treatments for reflux or blood thinners, so it’s worth reviewing your full medication list with your care team. Interactions can look very different from person to person, and coordinated care between your primary doctor, bone specialist, heart doctor, and dentist can help keep treatments aligned and side effects low.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described aching limbs that bowed with time, skulls that grew heavier, and joints that felt stiff long before old age. Families and communities once noticed patterns—an uncle with a large, misshapen shin, a grandparent whose hat size kept increasing—long before doctors connected these changes to Paget’s disease of bone.
First described in the medical literature as “osteitis deformans” in the late 1800s, the condition was named after Sir James Paget, who carefully documented the hallmark features: enlarged, weakened bones that remodel too quickly and irregularly. Early accounts came from clinic notes and autopsies, when X‑rays were new and blood tests were limited. Doctors recognized that certain bones—the pelvis, spine, skull, and long bones of the legs—were most often involved, and that the changes tended to appear in middle or later life.
Over time, descriptions became clearer as imaging and lab testing improved. Plain X‑rays revealed patchy thickening and areas of bone loss. Later, bone scans and specific blood markers helped map where Paget’s disease of bone was active and how fast it was progressing. These tools also showed a wide range of severity: some people had no symptoms and were found by chance, while others developed pain, bowed legs, hearing changes from skull involvement, or nerve pressure in the spine.
In recent decades, knowledge has built on a long tradition of observation. Researchers noticed that Paget’s disease of bone clustered in certain regions—parts of the UK, France, Spain, Italy, and New Zealand showed higher rates—suggesting both environmental influences and inherited risk. Family studies and DNA research now explain that variants in genes controlling bone turnover can raise susceptibility, although not everyone with a variant develops the condition. At the same time, public health changes and unknown factors may be linked to declining rates in some countries, a shift still being studied.
Once considered rare, now recognized as more common in older adults, the condition’s history mirrors advances in diagnosis and treatment. The introduction of modern bone-targeting medicines transformed care, moving from supportive measures toward treatments that can quiet overly active bone cells. Despite evolving definitions, the core story has stayed consistent: careful observation led to recognition, better tools sharpened understanding, and ongoing research continues to refine how Paget’s disease of bone is detected, monitored, and managed today.